SCHEMBL6680475

SCHEMBL6680475

CCNC(=NC(=O)OC(C)(C)C)Nc1ccc(OCc2ccccc2)c(CNC(=O)OC(C)(C)C)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.42
PTGER1 P34995 1/20 0.42
ESRRA P11474 1/20 0.41
CCR5 P51681 1/20 0.41
LMNA P02545 1/20 0.40
MAPT P10636 3/20 0.39
TDP1 Q9NUW8 3/20 0.39
MAPK1 P28482 1/20 0.39
C5AR1 P21730 4/20 0.39
PPARG P37231 1/20 0.39
PPARD Q03181 1/20 0.39
SYK P43405 1/20 0.39
KDM4E B2RXH2 2/20 0.38
P2RX4 Q99571 1/20 0.38
BRD4 O60885 1/20 0.38
HDAC1 Q13547 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
NAMPT P43490 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6674831 0.89 PTPN1 (0.39) ESRRAMAPTTDP1PPARDKMT2A
SCHEMBL6678686 0.86 ALDH1A1 (0.43) LMNAMAPTKDM4EMEN1KMT2A
SCHEMBL6681039 0.86 C5AR1 (0.39) CYP2C9PTGER1C5AR1SYKKDM4E
SCHEMBL6680473 0.85 CYP2C9 (0.42) CYP2C9PTGER1ESRRACCR5LMNA
SCHEMBL6676957 0.82 EGFR (0.43) MAPTTDP1HDAC1NAMPT
SCHEMBL6675952 0.81 CYP2C9 (0.45) CYP2C9PTGER1ESRRACCR5LMNA
SCHEMBL27564883 0.80 CYP2C9 (0.45) CYP2C9PTGER1ESRRACCR5LMNA
SCHEMBL6681429 0.78 C5AR1 (0.47) CYP2C9PTGER1MAPTC5AR1P2RX4
SCHEMBL6680479 0.77 CYP2C9 (0.39) CYP2C9PTGER1CCR5LMNAPPARG
SCHEMBL6681426 0.77 CYP2C9 (0.42) CYP2C9PTGER1ESRRACCR5LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0798292-B1 ANILINE DERIVATIVES HAVING NITROGEN MONOXIDE SYNTHASE INHIBITORY ACTIVITY CHUGAI SEIYAKUKABUSHIKI KAISHA (JP) 2004-11-03 EP disclosed
US-6534546-B1 Guanidine- or isothioureido-N-derived anilines; brain, nervous system, and neurodegenerative disorders CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-03-18 US disclosed
EP-0798292-A1 ANILINE DERIVATIVES HAVING NITROGEN MONOXIDE SYNTHASE INHIBITORY ACTIVITY Chugai Seiyaku Kabushiki Kaisha (JP) 1997-10-01 EP disclosed